title: [Relationship between essential arterial hypertension and osteoporosis:impact of antihypertensive treatment on extracellular metabolism of calcium].
authors.affiliation: Servicio de Farmacología Clínica, Facultad de Medicina, Universidad de Navarra, Pamplona.
authors.forename: J
authors.initials: J
authors.lastname: Honorato Pérez
authors.forename: M
authors.initials: M
authors.lastname: Escolar Jurado
authors.forename: E
authors.initials: E
authors.lastname: García Quetglas
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D015519:Bone Density; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use; D002136:Calcium, Dietary / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000494:pharmacology / Q000627:therapeutic use; D015444:Exercise; D005110:Extracellular Space / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000378:metabolism / Q000628:therapy; D008297:Male; D010024:Osteoporosis / Q000150:complications* / Q000209:etiology / Q000517:prevention & control; D051381:Rats; D011918:Rats, Inbred SHR
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D002136:Calcium, Dietary; D004232:Diuretics; D002118:Calcium